Five things for pharma marketers to know: Wednesday, April 5, 2017

Share this content:

1. GlaxoSmithKline, BMW, and Allstate have joined other companies that have pulled advertising from “The O'Reilly Factor” after sexual-harassment allegations against Bill O'Reilly, the host of the popular Fox News show, were published this weekend. (WSJ)

2. The FDA approved Austedo, a drug developed by Teva Pharmaceutical Industries to treat chorea, which is an involuntary movement disorder that affects the majority of people with Huntington's disease. (Reuters)

3. The latest proposal to replace the Affordable Care Act would allow states to waive the pre-existing conditions coverage requirement. (Politico)

4. A digital advertising company has been barred from using geofencing technology to send anti-abortion messages to women who visit reproductive health providers in Massachusetts. Geofencing technology directs ads to people's mobile devices when they enter certain locations. (WaPo)

5. ICYMI: The New York attorney general announced settlements with three mobile health apps after alleging that the developers misled consumers and used less-than-transparent privacy policies. (Wired)

Share this content:
Scroll down to see the next article